An update of the 2019 the Canadian Thoracic Society (CTS) Guideline provides “recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks
A guideline presents recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks to optimize maintenance pharmacologic therapy for individuals with stable
Using the case of a 66-year-old man with underlying chronic obstructive pulmonary disease (COPD) who presented to the emergency department with symptoms consistent with community-acquired
The use of the first generic maintenance inhaler approved for asthma and chronic obstructive pulmonary disease (COPD) produced outcomes similar to those with the original
In a phase 3 trial, dupilumab therapy improved outcomes in patients with COPD who had type 2 inflammation as indicated by elevated blood eosinophil counts.
Among new users of combination medication inhalers for chronic obstructive pulmonary disease (COPD), those on long-acting muscarinic antagonists (LAMAs) with long-acting β-agonists (LABAs) had a
In Taiwan, an analysis of a national insurance claims database shows potential differences in severe acute exacerbation (AEs) among fixed-dose combinations (FDCs) of long-acting muscarinic
The CAPTURE tool was ineffective in identifying undiagnosed, clinically important COPD in the primary care setting, researchers report. The tool “had a low sensitivity but
Among individuals with smoking exposure with and without COPD, a study identifies “risk factors for suicide/overdose … that emphasize the subjective experience of illness over
A meta-analysis of 60 randomized controlled trials examines all-cause mortality In 103,034 patients with COPD who were using inhaled therapy with or without inhaled corticosteroids